Partners Value Split Corp. to Redeem Its Class AA Preferred Shares, Series 11
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Partners Value Split Corp. (the “Company”) announced today its intention to redeem all of its 6,000,000 outstanding Class AA Preferred Shares, Series 11…
Correction: Form 8.3 – Octopus Investments
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION…
Sword Group: Investment in Cybersecurity and Artificial Intelligence
The Group is making a strategic operation in Scotland with the acquisition of iDelta, a cybersecurity and observability data specialist. iDelta, is a micro-company based in Edinburgh and specialising in…
Amesite (Nasdaq: AMST) Anticipates Sales Growth Amid Shifting Trade Dynamics
DETROIT, April 04, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today confirms that its operations remain unaffected by recently announced U.S. tariffs.…
Sword Group : Investissement dans la Cybersécurité et l’Intelligence Artificielle
Le Groupe réalise une opération stratégique en Écosse avec l’acquisition d’iDelta, une entreprise experte en cybersécurité et en analyse des données permettant de mieux surveiller et piloter les systèmes informatiques.…
Mohawk Industries, Inc. Invites You to Join its First Quarter Earnings Conference Call
CALHOUN, Ga., April 04, 2025 (GLOBE NEWSWIRE) -- In conjunction with Mohawk Industries’ (NYSE: MHK) First Quarter 2025 earnings release on Thursday, May 1, 2025, you are invited to listen…
Beam Therapeutics Presents Additional Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress
New Data Demonstrate Proportion of Corrected M-AAT Reached a Mean of 91% of Total AAT in Circulation at Day 28 Following BEAM-302 Treatment in 60 mg Cohort (n=3) Mean Decrease…
Appointment of CEO and CFO
The Board of Golden Ocean Group Ltd. ("Golden Ocean" or the "Company") is pleased to announce the appointment of Mr. Peder Simonsen as the Chief Executive Officer of Golden Ocean…
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine and importance of early and continued long-term treatment of chronic…
Mohawk Industries, Inc. le invita a unirse a la conferencia telefónica de los resultados financieros del primer trimestre
CALHOUN, Georgia, April 05, 2025 (GLOBE NEWSWIRE) -- En relación con la publicación de los resultados financieros de Mohawk Industries (NYSE: MHK) para el primer trimestre de 2025, el jueves,…